BIOV — Biovaxys Technology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Biovaxys Technology, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

	2018 October 31st	2019 October 31st	2020 October 31st	2021 October 31st	2022 October 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.016	0.229	2.42	0.593	0.142
Net Total Receivables	0.003	0.002	0.048	0.133	0.212
Prepaid Expenses
Total Current Assets	0.034	0.231	3.06	0.874	0.715
Net Property, Plant And Equipment	0.075	0.075	0	—	—
Net Intangible Assets
Long Term Notes Receivable
Total Assets	0.109	0.306	10.5	8.5	0.866
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.185	0.116	0.9	0.327	1.64
Total Long Term Debt
Total Debt
Total Liabilities	0.185	0.116	0.9	0.327	1.64
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.076	0.19	9.56	8.18	-0.774
Total Liabilities & Shareholders' Equity	0.109	0.306	10.5	8.5	0.866
Total Common Shares Outstanding